Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonolisib + Docetaxel in Advanced Solid Tumors (NSCLC and SCCHN)
NCT01204099Phase 2Completed
- Sponsor
- Cascadian Therapeutics
- Start
- Sep 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sonolisib in non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head and neck (HNSCC), sponsored by Cascadian Therapeutics. Started Sep 2010; status: completed.
02
Drugs
sonolisib
03
Conditions
non-small cell lung cancer (NSCLC)squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01204099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204099.